V-Capital and KHK & Partners led a $22m Series A round in TandemAI.

V-Capital, a private equity investment institution, and KHK & Partners, an independent asset management firm, led a $22m Series A round in TandemAI, a technology company dedicated to reinventing drug discovery infrastructure. “The financing is a strong vote of confidence in our progress to date and in our strategy. This funding will support AI and computational physics-based model development for multiple modalities, as well as wet lab capacity expansion to accommodate our rapidly growing client base," Jeff He, TandemAI Co-Founder and CEO.